Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Investigative Dermatology|November 9, 2000
Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosisC Fumelli, A Marconi, S Salvioli, et al.
Experimental Cell Research|February 27, 1999
Apoptotic features of peripheral blood granulocytes and monocytes during primary, acute HIV infectionA Cossarizza, C Mussini, V Borghi, et al.
Biogerontology|October 10, 2006
Effect of zinc ions on apoptosis in PBMCs from healthy aged subjectsR Ostan, S Alberti, L Bucci, et al.
Advances in Neuroimmunology|January 1, 1996
Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectorsE Oberholtzer, M Contarini, F Veglia, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1997
Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDSC Mussini, N Mongiardo, G Manicardi, et al.
Mechanisms of Ageing and Development|February 13, 2001
Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenariansR Gerli, D Monti, O Bistoni, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 29, 2000
Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine networkG P Bagnara, L Bonsi, P Strippoli, et al.
The Journal of Allergy and Clinical Immunology|May 18, 1999
Long-term immunologic effects of thymectomy in patients with myasthenia gravisR Gerli, R Paganelli, A Cossarizza, et al.
International Journal of Immunopathology and Pharmacology|January 4, 2006
Impairment of recent thymic emigrants in HCV infectionR Cianci, M Pinti, M Nasi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2015
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trialM Ripa, M Pogliaghi, S Chiappetta, et al.
Pageof 15